John Padro

I'll research this attorney before writing the summary.

Let me gather more detail on his background, prior firms, and case outcomes.

John Padro — Goodwin Procter LLP (New York)

Focus. Padro is a partner in Goodwin's IP Litigation group whose practice spans the intersection of computer science and life sciences. His firm bio and Legal 500 profile describe patent, trade secret, and contract/licensing disputes across consumer electronics, machine learning, biologicals, and biomedical devices, including smartphone- and FRAND-licensing work, biosimilar launches, and joint-venture/licensing disputes. His tracked case fits the life-sciences side of that practice: Tecan Genomics (formerly NuGEN Technologies) v. QIAGEN Sciences, a next-generation-sequencing target-enrichment patent suit involving nucleic-acid library preparation methods. He is not a Wi-Fi/standards specialist in the tracked data, though his bio references FRAND and licensing matters generally.

Side preference. The one tracked appearance is plaintiff-side (lead counsel for Tecan), and the web-verified client roster — LG Electronics, Renesas, Pfizer, Samsung Bioepis, Google, Abiomed, Biotronik, Nest, UCB, Tecan Genomics — is overwhelmingly operating companies rather than NPEs/PAEs. Tecan is a patent-owning operating company asserting its own patents, not a monetization entity. So he reads as an operating-company litigator who works both enforcement and defense, rather than a dedicated NPE plaintiff's lawyer; the tracked sample is too small to characterize a stable side preference, and he has also represented defendants in IPRs against Tecan's patents indirectly through the same family of cases.

Firm context and notable matters. He joined Goodwin in March 2023 as part of a three-partner IP litigation team (with Scott Weingaertner and Stefan Mentzer) recruited from White & Case, where he had been a partner and co-head of the firm's Hispanic affinity network. Before White & Case he worked in-house at WiPower, Inc., a wireless-power hardware/software startup, advising on IP and its sale to Qualcomm. The most prominent tracked matter is Tecan Genomics Inc. v. QIAGEN Sciences LLC (D. Del.), where he is lead counsel; the case is part of a broader Tecan/QIAGEN patent family ('012, '108, '241, '357 patents). I could not verify a final district-court judgment or verdict in that case, and the parallel PTAB proceedings produced mixed results (see below). His bio also cites engagements for LG Electronics, Pfizer, Samsung Bioepis, Google, and Abiomed, but specific verdicts or appellate outcomes are not publicly documented in the sources reviewed.

PTAB/IPR and credentials. Padro appears in PTAB proceedings as back-up counsel for Patent Owner Tecan Genomics in the QIAGEN IPRs (e.g., IPR2025-00026/-00027/-00028/-00029), admitted pro hac vice — he does not appear to be a registered patent practitioner. Those proceedings were not uniformly favorable to his client: the Board instituted trial on the '241 and '399 patents, and Tecan disclaimed all challenged claims of each after institution, leading to adverse judgment; the Board also instituted on the '012 patent (IPR2025-00028, instituted May 2025). Bar admissions: New York and Florida; admitted in the S.D.N.Y., the Second Circuit, and the Federal Circuit. Education: J.D., Columbia Law School (2009); B.S., Electrical Engineering, and B.A., Political Science, University of Florida (2006). Recognitions include Legal 500 (Trade Secret, 2024–2026) and Managing IP Patent Notable Practitioner (2023–2026); he was shortlisted for Euromoney LMG's Rising Star – Patents in 2020.

Note: the tracked appearance count (1) reflects this dataset only and understates his overall litigation docket; the additional matters above are drawn from firm/press sources and are not independently verified for outcomes.